尿蛋白与尿白蛋白评估CKD肾衰竭风险的比较
该研究基于日本慢性肾脏病队列,分析2年内尿蛋白肌酐比(UPCR)或尿白蛋白肌酐比(UACR)下降30%与后续需替代治疗的肾衰竭(KFRT)风险的关联。在603例有2年UPCR与UACR数据的患者中,UPCR下降30%与KFRT风险降低相关(HR 0.52),UACR结果相当(HR 0.58);eGFR<15 ml/min/1.73 m²者UPCR变化关联较弱,需谨慎解读。
要点
- 2年内UPCR或UACR下降30%均可作为KFRT的替代终点指标。
- UPCR下降30%与KFRT风险降低相关,HR 0.52(0.38, 0.71)。
- eGFR<15 ml/min/1.73 m²时UPCR变化的关联弱于UACR,应谨慎解读。
核心结论
- 在CKD患者中,2年内UPCR或UACR下降30%可能作为后续KFRT的相当替代终点。
- 对eGFR<15 ml/min/1.73 m²的患者需谨慎解读UPCR变化的关联。
研究设计与样本
- 基于日本慢性肾脏病队列(CKD Japan Cohort)数据的事后分析。
- 共2966例患者,其中603例有2年UACR与UPCR数据,831例有1年UPCR数据。
- 采用多变量Cox比例风险模型评估关联。
主要发现
- 603例患者平均年龄60岁,平均eGFR 29 ml/min/1.73 m²,中位UPCR 0.81 g/gCr,中位UACR 601 mg/gCr。
- 中位随访4.9年期间245例(40.6%)进展至KFRT。
- 2年UPCR下降30%与KFRT风险降低相关,HR 0.52(0.38, 0.71);UACR结果相当,HR 0.58(0.41, 0.82)。
- 831例中1年UPCR下降30%与KFRT风险降低相关,HR 0.56(0.43, 0.73)。
- 亚组分析显示多数基线特征下关联一致,但eGFR<15 ml/min/1.73 m²者UPCR变化关联弱于UACR。
临床怎么用
- 在临床中可将2年内UPCR或UACR下降30%作为CKD进展风险的替代评估指标。
- 对eGFR<15 ml/min/1.73 m²的患者,优先参考UACR变化而非UPCR变化。
局限性
- UPCR与UACR同时可用的患者仅603例,样本量有限。
- 为观察性队列分析,不能确立因果关系。
- eGFR<15 ml/min/1.73 m²亚组中UPCR关联减弱,可能反映尿白蛋白与蛋白比值降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: The urinary albumin-to-creatinine ratio (UACR) is an established surrogate endpoint for kidney failure in chronic kidney disease (CKD). However, proteinuria remains widely used in routine clinical practice in several countries due to its accessibility and cost-effectiveness. Moreover, the comparative utility of UACR and proteinuria as surrogate endpoints is not well-defined. METHODS: We analyzed data from the Chronic Kidney Disease Japan Cohort to examine the association between a 30% decrease in urinary protein-to-creatinine ratio (UPCR) or UACR over 2 years and the subsequent risk of kidney failure requiring replacement therapy (KFRT). We also examined the relationship between a 30% decrease in UPCR over 1 year and the risk of KFRT. Associations were evaluated using multivariable Cox proportional hazards models. RESULTS: Among the 2966 patients, 603 had both UACR and UPCR data available over 2 years. Their mean age was 60 years, mean estimated glomerular filtration rate (eGFR) was 29 ml/min/1.73 m², median UPCR was 0.81 g/gCr, and median UACR was 601 mg/gCr. During a median follow-up of 4.9 years, 245 patients (40.6%) progressed to KFRT. A 30% decrease in UPCR over 2 years was significantly associated with a lower risk of KFRT [hazard ratio (HR), 0.52 (0.38, 0.71)], with comparable findings for UACR [HR, 0.58 (0.41, 0.82)]. A similar association was observed for UPCR over 1 year among 831 patients [HR 0.56 (0.43, 0.73)]. Subgroup analyses showed consistent associations across most baseline characteristics. Nevertheless, the association of UPCR change was weaker than that of UACR change in patients with eGFR < 15 ml/min/1.73 m², possibly reflecting the reduced urinary albumin-to-protein ratio. CONCLUSIONS: In patients with CKD, a 30% decrease in UPCR or UACR over 2 years may serve as a comparable surrogate endpoint for subsequent KFRT. Nonetheless, caution is warranted in patients with eGFR < 15 ml/min/1.73 m².
引用
- Toyama T, Imaizumi T, Hamano T, et al. Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease. Nephrol Dial Transplant. 2026. PMID: 42366630. doi:10.1093/ndt/gfag122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。